Literature DB >> 8700513

S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase.

D Spitkovsky1, P Jansen-Dürr, E Karsenti, I Hoffman.   

Abstract

Adenovirus E1A proteins can induce quiescent cells to enter S-phase and also affect the expression of cellular genes including various cell cycle regulators. Here we show that human cdc25A, a tyrosine phosphatase involved in regulation of the G1/S-phase transition of the cell cycle, is a target of the adenovirus E1A protein in virus-infected human fibroblasts. Expression of E1A in quiescent fibroblasts leads to a rapid increase in cdc25A phosphatase activity and also increases both cdc25A and cyclin E gene expression. Inhibition of cdc25A function by antibody injection prevents virus-induced entry into S-phase. These results indicate that induction of high levels of cdc25A and its potential positive regulator cyclin E mediates the ability of E1A to induce S-phase in the presence of antiproliferative signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700513

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

2.  Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.

Authors:  Don X Nguyen; Thomas F Westbrook; Dennis J McCance
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease.

Authors:  X L Ding; J Husseman; A Tomashevski; D Nochlin; L W Jin; I Vincent
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E.

Authors:  L G Martin; G W Demers; D A Galloway
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.

Authors:  Zhihui Wang; Claes G Trope; Vivi Ann Flørenes; Zhenhe Suo; Jahn M Nesland; Ruth Holm
Journal:  BMC Cancer       Date:  2010-05-25       Impact factor: 4.430

7.  Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.

Authors:  Xinyu Zheng; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Hongying Hao; Kelly M McMasters; H Sam Zhou
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

8.  Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.

Authors:  Stephan Leitner; Katrina Sweeney; Daniel Oberg; Derek Davies; Enrique Miranda; Nick R Lemoine; Gunnel Halldén
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

9.  A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).

Authors:  K Alevizopoulos; B Catarin; J Vlach; B Amati
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

10.  Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.

Authors:  Claire M Connell; Atsushi Shibata; Laura A Tookman; Kyra M Archibald; Magdalena B Flak; Katrina J Pirlo; Michelle Lockley; Sally P Wheatley; Iain A McNeish
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.